SMO Clinplus Co (SZSE:301257) Change In Receivables : ¥0.0 Mil (TTM As of Mar. 2024)

View and export this data going back to 2022. Start your Free Trial

What is SMO Clinplus Co Change In Receivables?

SMO Clinplus Co's change in receivables for the quarter that ended in Mar. 2024 was ¥0.0 Mil. It means SMO Clinplus Co's Accounts Receivable stayed the same from Dec. 2023 to Mar. 2024 .

SMO Clinplus Co's change in receivables for the fiscal year that ended in Dec. 2023 was ¥-103.8 Mil. It means SMO Clinplus Co's Accounts Receivable increased by ¥103.8 Mil from Dec. 2022 to Dec. 2023 .

SMO Clinplus Co's Accounts Receivable for the quarter that ended in Mar. 2024 was ¥113.3 Mil.

Days Sales Outstanding measures of the average number of days that a company takes to collect revenue after a sale has been made. It is a financial ratio that illustrates how well a company's Accounts Receivable are being managed. SMO Clinplus Co's Days Sales Outstanding for the three months ended in Mar. 2024 was 56.03.

In Ben Graham's calculation of liquidation value, Apple Inc's Accounts Receivable are only considered to be worth 75% of book value. SMO Clinplus Co's liquidation value for the three months ended in Mar. 2024 was ¥725.2 Mil.

SMO Clinplus Co Change In Receivables Historical Data

The historical data trend for SMO Clinplus Co's Change In Receivables can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

SMO Clinplus Co Change In Receivables Chart

SMO Clinplus Co Annual Data

Trend

Dec17

Dec18

Dec19

Dec20

Dec21

Dec22

Dec23

Change In Receivables

Get a 7-Day Free Trial

-21.61

-70.08

-83.78

-85.09

-103.83

SMO Clinplus Co Quarterly Data
	Dec17	Dec18	Dec19	Mar20	Jun20	Sep20	Dec20	Mar21	Jun21	Sep21	Dec21	Mar22	Jun22	Sep22	Dec22	Mar23	Jun23	Sep23	Dec23	Mar24
Change In Receivables	Get a 7-Day Free Trial															-	-	-	-	-

SMO Clinplus Co Change In Receivables Calculation

Change In Accounts Receivable relative to the previous period. It is any increase or decrease in the cash a company is owed by its customers.

Change In Receivables for the trailing twelve months (TTM) ended in Mar. 2024 adds up the quarterly data reported by the company within the most recent 12 months, which was ¥0.0 Mil.

SMO Clinplus Co (SZSE:301257) Change In Receivables Explanation

1. Accounts Receivable are created when a customer has received a product but has not yet paid for that product. Days Sales Outstanding measures of the average number of days that a company takes to collect revenue after a sale has been made. It is a financial ratio that illustrates how well a company's Accounts Receivable are being managed.

SMO Clinplus Co's Days Sales Outstanding for the quarter that ended in Mar. 2024 is calculated as:

	Days Sales Outstanding
=	Accounts Receivable	/	Revenue	*	Days in Period
=	113.299	/	184.533	*	91
=	56.03

2. In Ben Graham's calculation of liquidation value, SMO Clinplus Co's accounts receivable are only considered to be worth 75% of book value:

SMO Clinplus Co's liquidation value for the quarter that ended in Mar. 2024 is calculated as:

	Liquidation Value
=	Cash, Cash Equivalents, Marketable Securities	-	Total Liabilities	+	(0.75 * Accounts Receivable)	+	(0.5 * Total Inventories)
=	905.092	-	264.852	+	0.75 * 113.299	+	0.5 * 0
=	725.2

SMO Clinplus Co Change In Receivables Related Terms

Thank you for viewing the detailed overview of SMO Clinplus Co's Change In Receivables provided by GuruFocus.com. Please click on the following links to see related term pages.

SMO Clinplus Co (SZSE:301257) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Diagnostics & Research » SMO Clinplus Co Ltd (SZSE:301257) » Definitions » Change In Receivables

Comparable Companies

Traded in Other Exchanges

N/A

Address

No. 105 Sinan Road, Room 108, Building 1, Huangpu District, Shanghai, CHN, 200001

Website

http://www.smo-clinplus.com

SMO Clinplus Co Ltd is engaged in providing SMO services to domestic and foreign pharmaceutical companies, medical device companies and clinical research and development of some health-related products. The services provided include Preliminary model establishment, Preliminary plan preparation, Initiation of clinical trial sites, On-site implementation, and Comprehensive project management.

Executives

Lai Chun Bao	Director
Ma Lin	Director

SMO Clinplus Co (SZSE:301257) Headlines

No Headlines